JY
INBS icon

Jeff Yass’s Intelligent Bio Solutions INBS Stock Holding History

Jeff Yass’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,549
Closed -$51.1K – 13164
2025
Q1 		$51.1K Buy
+3,549
New +$66.2K ﹤0.01% 11855
2022
Q3 		– Sell
-14
Closed -$22K – 13629
2022
Q2 		$22K Buy
+14
New +$23.6K ﹤0.01% 12342

Other funds holding INBS

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jeff Yass's INBS Position: Q2 2025 in Review

Jeff Yass sold out of Intelligent Bio Solutions (INBS) in Q2 2025, closing a stake of 3,549 shares — an estimated $51.1K sold.

Jeff Yass first reported a position in INBS in Q2 2022 and held it in 2 quarters. The position peaked at $51.1K in Q1 2025. 9 funds tracked by Wall St. Rank hold INBS as of Q2 2025.

  • Jeff Yass reported no remaining Intelligent Bio Solutions position as of Q2 2025 after selling out during the quarter.
  • Jeff Yass sold 3,549 Intelligent Bio Solutions shares in Q2 2025, an estimated $51.1K.
  • Jeff Yass first reported a position in Intelligent Bio Solutions in Q2 2022 and held it in 2 quarters.
  • Jeff Yass's Intelligent Bio Solutions position peaked at $51.1K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.